Patents by Inventor Daniel Knutson

Daniel Knutson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ligands selective to alpha 6 subunit-containing GABAA receptors and their methods of use
    Patent number: 11427582
    Abstract: Provided herein are novel pyrazoloquinolinone compounds and method of using such compounds to treat disorders such as neuropsychiatric disorders with sensorimotor gating deficits, such as schizophrenia, tic disorders, attention deficit hyperactivity disorder, obsessive compulsive disorder, panic disorder, Huntington's disease and nocturnal enuresis; depression; temporomandibular myofascial pain; disorders of trigeminal nerve, such as trigeminal neuralgia and trigeminal neuropathy; migraine; and tinnitus.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: August 30, 2022
    Assignee: UWM Research Foundation, Inc.
    Inventors: James Cook, Daniel Knutson
  • LIGANDS SELECTIVE TO ALPHA 6 SUBUNIT-CONTAINING GABAA RECEPTORS AND THEIR METHODS OF USE
    Publication number: 20210047322
    Abstract: Provided herein are novel pyrazoloquinolinone compounds and method of using such compounds to treat disorders such as neuropsychiatric disorders with sensorimotor gating deficits, such as schizophrenia, tic disorders, attention deficit hyperactivity disorder, obsessive compulsive disorder, panic disorder, Huntington's disease and nocturnal enuresis; depression; temporomandibular myofascial pain; disorders of trigeminal nerve, such as trigeminal neuralgia and trigeminal neuropathy; migraine; and tinnitus.
    Type: Application
    Filed: October 23, 2020
    Publication date: February 18, 2021
    Inventors: Lih-Chu Chiou, James Cook, Margot Ernst, Pi-Chuan Fan, Daniel Knutson, Matheus Meirelles, Marko Mihovilovic, Werner Sieghart, Zdravko Varagic, Ranjit Verma, Laurin Wimmer, Christopher Witzigmann, David Chan Bodin Siebert, Miroslav M. Savic
  • Ligands selective to alpha 6 subunit-containing GABAA receptors and their methods of use
    Patent number: 10865203
    Abstract: Provided herein are novel pyrazolo-quinolinone compounds and method of using such compounds to treat disorders such as neuropsychiatric disorders with sensorimotor gating deficits, such as schizophrenia, tic disorders, attention deficit hyperactivity disorder, obsessive compulsive disorder, panic disorder, Huntington's disease and nocturnal enuresis; depression; temporomandibular myofascial pain; disorders of trigeminal nerve, such as trigeminal neuralgia and trigeminal neuropathy; migraine; and tinnitus.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: December 15, 2020
    Assignees: UWM Research Foundation, Inc., Medical University of Vienna
    Inventors: James Cook, Daniel Knutson, Marko Mihovilovic, Laurin Wimmer
  • LIGANDS SELECTIVE TO ALPHA 6 SUBUNIT-CONTAINING GABAA RECEPTORS AND THEIR METHODS OF USE
    Publication number: 20180134698
    Abstract: Provided herein are novel pyrazolo-quinolinone compounds and method of using such compounds to treat disorders such as neuropsychiatric disorders with sensorimotor gating deficits, such as schizophrenia, tic disorders, attention deficit hyperactivity disorder, obsessive compulsive disorder, panic disorder, Huntington's disease and nocturnal enuresis;depression; temporomandibular myofascial pain; disorders of trigeminal nerve, such as trigeminal neuralgia and trigeminal neuropathy; migraine; and tinnitus.
    Type: Application
    Filed: June 3, 2016
    Publication date: May 17, 2018
    Inventors: Lih-Chu Chiou, James Cook, Margot Ernst, Pi-Chuan Fan, Daniel Knutson, Matheus Meirelles, Marko Mihovilovic, Werner Sieghart, Zdravko Varagic, Ranjit Verma, Laurin Wimmer, Christopher Witzigmann, David Chan Bodin Siebert, Miroslav M. Savic